| 1 | Study | 2.26% | |
| 2 | Pediatric | 1.13% | |
| 3 | Lymphoma | 1.13% | |
| 4 | SA | 1.13% | |
| 5 | Pivotal | 0.56% | |
| 6 | Control | 0.56% | |
| 7 | Cavaliere | 0.56% | |
| 8 | Reid | 0.56% | |
| 9 | Reduced | 0.56% | |
| 10 | Offers | 0.56% | |
| 11 | Factors | 0.56% | |
| 12 | Titers | 0.56% | |
| 13 | LISTEN | 0.56% | |
| 14 | Caused | 0.56% | |
| 15 | Gut | 0.56% | |
| 16 | Central | 0.56% | |
| 17 | Speckle-Tracking | 0.56% | |
| 18 | Burlington | 0.56% | |
| 19 | Pump | 0.56% | |
| 20 | Lo | 0.56% | |
| 21 | Academic | 0.56% | |
| 22 | Resistance | 0.56% | |
| 23 | Nerve | 0.56% | |
| 24 | Detection | 0.56% | |
| 25 | Yale | 0.56% | |
| 26 | Antibody | 0.56% | |
| 27 | Indicator | 0.56% | |
| 28 | Inhibitor | 0.56% | |
| 29 | Rapid | 0.56% | |
| 30 | Highlights | 0.56% | |
| 31 | Parsons | 0.56% | |
| 32 | Randomized | 0.56% | |
| 33 | Liquid | 0.56% | |
| 34 | Sobi | 0.56% | |
| 35 | Could | 0.56% | |
| 36 | Overlap | 0.56% | |
| 37 | Complexity | 0.56% | |
| 38 | Part | 0.56% | |
| 39 | NWEA | 0.56% | |
| 40 | Energy | 0.56% | |
| 41 | Comorbidities | 0.56% | |
| 42 | Therapy | 0.56% | |
| 43 | New | 0.56% | |
| 44 | Caudal | 0.56% | |
| 45 | Family | 0.56% | |
| 46 | Controlled | 0.56% | |
| 47 | Elderly | 0.56% | |
| 48 | Antimuscarinic | 0.56% | |
| 49 | Multiple | 0.56% | |
| 50 | FFMI | 0.56% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||